Aptevo Therapeutics Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Aptevo Therapeutics Inc. (APVO) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$25.97 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-26
- Aptevo Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$25.97M.
- Aptevo Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$24.13M.
- Aptevo Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$18.65M, a 365.90% decline from fiscal 2022.
- Aptevo Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $7.01M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$25.97M 10-K · filed 2026-03-26 | |
| 2024-12-31 | -$24.13M 10-K · filed 2026-03-26 | |
| 2023-12-31 | -$18.65M 10-K · filed 2025-02-14 | |
| 2022-12-31 | $7.01M 10-K · filed 2024-03-05 | |
| 2021-12-31 | -$29.41M 10-K · filed 2023-03-30 | |
| 2020-12-31 | -$30.92M 10-K · filed 2022-03-24 | |
| 2019-12-31 | -$43.06M 10-K · filed 2021-03-31 | -$44.70M 10-K · filed 2020-03-25 |
| 2018-12-31 | -$53.69M 10-K · filed 2020-03-25 | |
| 2017-12-31 | -$55.88M 10-K · filed 2019-03-18 | |
| 2016-12-31 | -$139.58M 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |